Please select a Capability in order to start your service request.
Pap tests have been used since the 1950s to screen cervical cancer with success, but they have also presented many limitations. Developed in the 1990s, liquid-based cytology (LBC) today brings improvements to laboratories, doctors and patients—in every step of the process, from collection to results.1
The BD SurePath liquid-based Pap Test is the liquid-based cytology test from BD. Offering proprietary features and benefits, the test provides advantages over conventional Pap smears and other LBC tests.